Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cardiol Therapeutics Inc. T.CRDL

Alternate Symbol(s):  CRDL | T.CRDL.W.A

Cardiol Therapeutics’ lead product, CardiolRx™, is an oral pharmaceutical that is currently being evaluated in the Phase II multi-national ARCHER trial in patients presenting with acute myocarditis. Cardiol has received IND authorization from the FDA to conduct a clinical study to evaluate CardiolRx™ in a Phase II multi-center open-label pilot study in recurrent pericarditis. Cardiol is developing a subcutaneously administered drug formulation of cannabidiol intended for use in heart failure.


Cardiol Therapeutics Inc. > RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CRDL will rise like a Phoenix

{{labelSign}}  Favorites
{{errorMessage}}

December 10, 2020 - 09:45 AM
43 Reads
Post# 32075839

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CRDL will rise like a Phoenix

think page 4 ,, from your other Identy

RE:RE:RE:Upswing

Still find it funny?
Maybe u should listen Patty.
Anyone could see this coming if you look at the chart.